semaglutide in leg Injecting Semaglutide: A Guide to Injection Sites and Technique ACC 2025: Semaglutide Significantly Improves

This is particularly relevant for individuals using cagrilintide alongside insulin or sulfonylureas

Participants in the SGLT2i group demonstrated improvement in renal function with an increase in mean eGFR over the 5-year follow-up period (+3.5 ml/min per 1.73 m 2 ), compared with an overall reduction in eGFR in the GLP-1 RA cohort (7.2 ml/min per 1.73 m 2 )

Glucagon-like peptide-1 (GLP-1) receptor agonists have gained attention primarily as weight-loss tools, but emerging clinical evidence suggests their therapeutic range extends well beyond the scale

Ozempic and Rybelsus are approved for long-term use in managing type 2 diabetes and related conditions

Outcomes included GLP-1 RA use and all-cause and diabetes-related health care costs, including medical and prescription drug costs paid by patients and insurers